COFCO Biotech's citric acid revenue jumps in H1

COFCO Biotechnology Co., Ltd. (COFCO Biotech) launched its H1 2022 Financial Report on 24 Aug.Kay data for H1 shows that revenue from citric acids and the by-products jumped 184.12% YoY to USD149.31 million (RMB1.06 billion), accounting for 9.95% of ...

Acidity Regulator Quarterly China Report Q3 2022

www.cnchemicals.com